Replies to post #49104 on Nutra Pharma Corp (NPHC)

[cngreen]

Fun Fact. Aspirin was never approved by the FDA.

[cngreen]

Not all Cannabis is created equal. I can tell you definitively that cancer patients use Cannabis for pain cause it works.

First-hand knowledge from a family member.

Cannabis was supposed to relieve pain but when subjected to double blind studies by GWP it failed to mitigate the pain in cancer patients.

[otcbbnpink]

You can say what you like about "anecdotal reports" - their products absolutely work.

Nyloxin has changed my life and Pet Pain-Away has helped dozens of dogs and cats for me and my friends. A nice note: there's no placebo effect in a dog or cat. When you give a dog that can barely move the Pet Pain-Away and they start running around like a puppy - - - you know that the product works.

There are tons of companies out there that are trading at higher market values than NPHC that have NO products, NO revenues and smaller potential markets for their products.

NPHC has revenues - a few hundred thousand now can turn into millions in the next year. They have real products that are going through trials and have been reviewed by the FDA. Orphan Designation requires a review process and designation approval - which they only give on a strong rationale for potential approval.

In a nutshell - NPHC has a LOT more going for it than other companies in their space that are trading at billion dollar valuations. That means:

UP UP UP UP .....

Again - JMHO

[ThinkingOutLoud]

Great points I-Glow. The FDA will not approve a drug unless the manufacturer can provide studies which are : Double-blind, placebo-controlled, published and peer-reviewed.

I submitted that alert 3 years ago.
Source: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=134877446

Source: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136184130

Presumably, some heeded my warnings and moved on. As bad as my prognostication was then, it’s far worse now, assuming; the SEC staff is under tremendous pressure to justify prioritizing its investigation and prosecutorial budget.

Thinking